Sat.Feb 01, 2025

article thumbnail

Fitusiran Is a Drug to Watch in the Hematology Space in 2025

Pharmacy Times

Fitusiran is part of a generation of novel RNA interference therapies and is designed for subcutaneous administration for the prophylactic treatment of hemophilia A or B.

49
article thumbnail

FDA Approves Diagnostic Label Expansion for HR+, HER2–Ultra-Low Metastatic Breast Cancer

Pharmacy Times

The diagnostic identifies patients who may be eligible for treatment with fam-trastuzumab-deruxtecan-nxki (Enhertu; Daiichi-Sankyo, AstraZeneca).

FDA 29
article thumbnail

Key Themes at COA 2025 Community Oncology Conference for Pharmacists

Pharmacy Times

Judith Alberto, MHA, RPh, BCOP, discusses the COA 2025 Community Oncology Conference, emphasizing its focus on transparency in oncology and the role of data in supporting pharmacists' contributions to patient care.